Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:ATCCode |
L01EL05
|
| gptkbp:CASNumber |
1809770-02-5
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Cogent_Biosciences
|
| gptkbp:hasMolecularFormula |
C27H27F3N6O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
bezuclastinib
|
| gptkbp:indication |
gptkb:gastrointestinal_stromal_tumor
gptkb:systemic_mastocytosis |
| gptkbp:isInvestigational |
true
|
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:molecularWeight |
524.54 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
CGT9486
PLX9486 |
| gptkbp:target |
gptkb:KIT
|
| gptkbp:UNII |
6Q1K1Q1Q1E
|
| gptkbp:bfsParent |
gptkb:Cogent_Biosciences
|
| gptkbp:bfsLayer |
8
|